You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis

Authors

  • Evelien Zonneveld-Huijssoon 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Femke van Wijk 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Sarah Roord 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Eveline Delemarre 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Jenny Meerding 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Wilco de Jager 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Mark Klein 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Eyal Raz 2Department of Medicine, University of California San Diego, San Diego, California, USA PubMed articlesGoogle scholar articles
  • Salvatore Albani 3Translational Research Laboratory, Inflammatory and Infectious Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, USA4EUREKA Institute for Translational Medicine, Siracusa, Italy PubMed articlesGoogle scholar articles
  • Wietse Kuis 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Marianne Boes 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Berent J Prakken 1Department of Pediatric Immunology, Centre for Molecular and Cellular Intervention, University Medical Centre Utrecht, Utrecht, The Netherlands4EUREKA Institute for Translational Medicine, Siracusa, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Berent J Prakken, Department of Pediatric Immunology, University Medical Centre Utrecht, Centre for Molecular and Cellular Intervention, Lundlaan 6, 3584 EA Utrecht, The Netherlands; b.prakken{at}umcutrecht.nl
View Full Text

Citation

Zonneveld-Huijssoon E, van Wijk F, Roord S, et al
TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis
Annals of the Rheumatic Diseases 2012;71:1706-1715.

Publication history

  • Accepted March 12, 2012
  • First published May 5, 2012.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions